| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |